Citation Impact
Citing Papers
Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant
1995
Interferon-α-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression
2005
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders
2002
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Cocaine increases 5-HT1B mRNA in rat nucleus accumbens shell neurons
2006
The Corticosteroid Receptor Hypothesis of Depression
2000 Standout
5-Hydroxytryptamine pathways in anxiety and its treatment
1995
The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes
2003 Standout
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
2005 Standout
Inhibition of Serotonin But Not Norepinephrine Transport during Development Produces Delayed, Persistent Perturbations of Emotional Behaviors in Mice
2008
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
2011 Standout
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
2009 Standout
Repeated predictable or unpredictable stress: effects on cocaine-induced locomotion and cyclic AMP-dependent protein kinase activity
2003
Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice
2003
Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs
2003
Neural regulation of endocrine and autonomic stress responses
2009 Standout
Is the forced swimming test a suitable model for revealing antidepressant activity?
1988
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity
2008 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Effects of stress throughout the lifespan on the brain, behaviour and cognition
2009 Standout
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features
2015 Standout
Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters
2001
Changes in anxiety-related behaviors and hypothalamic–pituitary–adrenal activity in mice lacking the 5-HT-3A receptor
2004 StandoutNobel
Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice
2010
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Interaction between glucocorticoid hormones, stress and psychostimulant drugs*
2002
5-HT3 receptor antagonists and anxiety; a preclinical and clinical review
2000
Cytokines sing the blues: inflammation and the pathogenesis of depression
2005 Standout
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
2003 Standout
Methamphetamine Reward in Mice as Assessed by Conditioned Place Preference Test with Supermex® Sensors: Effect of Subchronic Clorgyline Pretreatment
2006
Evidence for postsynaptic mediation of the hypothermic effect of 5‐HT1A receptor activation
1992
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner
2012 Standout
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
2001
Selective Blockade of Drug-induced Place Preference Conditioning by ACPC, a Functional NDMA-receptor Antagonist
2002
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
The age of anxiety: role of animal models of anxiolytic action in drug discovery
2011
Chronic stress: Implications for neuronal morphology, function and neurogenesis
2007
Stress and the brain: from adaptation to disease
2005 Standout
Clinical and Biochemical Effects of Catecholamine Depletion on Antidepressant-Induced Remission of Depression
1996
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Stress and Cocaine Addiction
2002
Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression
1999
Systematic Review and Meta-analysis
2008 Standout
The HPA axis in major depression: classical theories and new developments
2008 Standout
A review of central 5-HT receptors and their function
1999 Standout
Major Depressive Disorder
2008 Standout
Genetic alteration of the α2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels
1999 StandoutNobel
Psychosis pathways converge via D2High dopamine receptors
2006
Increased synaptic availability of norepinephrine following desipramine is not essential for increases in GR mRNA
1997
Steroid-Independent Translocation of the Glucocorticoid Receptor by the Antidepressant Desipramine
1997
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Effect of the Glucocorticoid Receptor Antagonist Org 34850 on Basal and Stress‐Induced Corticosterone Secretion
2007
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?
2005
Neurocircuitry of Addiction
2009 Standout
The Neuroprotective Effect of Curcumin and Nigella sativa Oil Against Oxidative Stress in the Pilocarpine Model of Epilepsy: A Comparison with Valproate
2011
Reversal by imipramine of β-adrenoceptor up-regulation induced in a chronic mild stress model of depression
1994
The debate over dopamine’s role in reward: the case for incentive salience
2006 Standout
Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review
2006
A review on therapeutic potential of Nigella sativa: A miracle herb
2013 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH 23390
1988 StandoutNobel
A Molecular and Cellular Theory of Depression
1997 Standout
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses
2016 Standout
Correlations between different measures of antiserotonin activity of drugs
1982
Elevated Expression of 5-HT1BReceptors in Nucleus Accumbens Efferents Sensitizes Animals to Cocaine
2002
Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors
1985 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
The Effects of Neurosteroids on Rat Behavior and 3H-Muscimol Binding in the Brain
1999
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Shuttle-box deficits induced by inescapable shocks in rats: Reversal by the beta-adrenoreceptor stimulants clenbuterol and salbutamol
1986
The Neuropsychology of Anxiety
2003 Standout
Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents
1979
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
Dopamine receptor-mediated hypothermia induced in rats by (+)-, but not by (—)-3-PPP
1985 StandoutNobel
Prenatal bupropion exposure enhances the cocaine reward and stress susceptibility in adult mice.
2005
Works of J Siwanowicz being referenced
Protective effects of neurosteroids against NMDA-induced seizures and lethality in mice
1998
The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats
1993
Effect of Antidepressant Drugs in Mice Lacking the Norepinephrine Transporter
2006
Effect of serotonin (5-HT) 1B receptor ligands on cocaine sensitization in rats
2001
Activation of serotonin (5-HT)1A receptors inhibits amphetamine sensitization in mice
2000
Long-term exposure of rats to tramadol alters brain dopamine and α1-adrenoceptor function that may be related to antidepressant potency
2004
Role of 5-HT1B receptors in the sensitization to amphetamine in mice
2001
Effects of tramadol on α2-adrenergic receptors in the rat brain
2004
The effect of chronic treatment with antidepressant drugs on the corticosteroid receptor levels in the rat hippocampus.
1995
Effects of corticosterone and its synthesis blockade on the cocaine-induced discriminative stimulus effects in rats.
2001
The effect of some new antidepressants on apomorphine-induced hypothermia in mice
1979
Effect of adrenalectomy and corticosterone on cocaine-induced sensitization in rats.
2000
Lack of effect of a glycine(B) receptor partial agonist on amphetamine-induced sensitization in mice.
2000
The role of nitric oxide in chemically- and electrically-induced seizures in mice
1996
The effect of chronic treatment with antidepressant drugs on salbutamol-induced hypoactivity in rats
1983
The central action of pizotifen
1979
Repeated treatment with antidepressant drugs prevents salbutamol-induced hypoactivity in rats
1984
The anxiolytic-like effects of 5-hydroxytryptamine3 (5-HT3) receptor antagonists.
1993
Psychopharmacological profile of dexamisole.
1981
Repeated treatment with imipramine, amitriptyline or electroconvulsive shock does not affect the 8-OH-DPAT-induced increase in food intake in free feeding rats.
1991
Captopril lacks the antidepressant-like activity in animal models.
1992